Last edition
News about "Renée Aguiar-Lucander"
Hansa Biopharma Signs IDEFIRIX Licensing Deal with SERB Pharmaceuticals for Europe and MENA
Hansa Biopharma signs a €115 million licensing agreement with SERB Pharmaceuticals for commercialisation of IDEFIRIX across Europe and MENA, strengthening its financial position ahead of a potential US launch.
Renée Aguiar-Lucander | 21/05/2026 | By News Bureau
Hansa Biopharma's Imlifidase BLA Accepted by US FDA for Priority Review
FDA accepts Hansa Biopharma’s BLA for imlifidase, supported by strong Phase III ConfIdeS data demonstrating significant kidney function improvement in highly sensitized transplant patients.
Renée Aguiar-Lucander | 20/02/2026 | By News Bureau | 352
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy